The Directors and team at Chitogel are delighted to welcome onboard Blair Stewart ,as our new CEO.
As Chitogel continues its international expansion, Blair’s capability and experience in growing global businesses will bring to bear a new set of skills, at exactly the right time. Blair has worked in Senior roles at Fonterra, MoleMap and Baxter Healthcare and understands many of the opportunities and challenges around breaking into new markets and driving sales globally.
As Chitogel launches into Europe and Australia over the coming months, having a CEO of Blair’s calibre will be invaluable.
Andrew has done a wonderful job as Acting CE over the past year in a challenging but fruitful US market and will move back to his GM Operations role. I would like to thank him for his efforts.
It is great to start filling out our team to enhance our move into these markets and continue our research and development develop efforts on our exciting pipeline of new and improved products that will improve patient outcomes. We now have a growing group of world-leading ENT surgeons that are passionate supporters of Chitogel as one of the first scientifically proven and highly effective post-operative nasal gels to demonstrate real and practical advances in post-operative wound healing.
Welcome on board Blair.